Literature DB >> 16337602

Dual roles for DNA polymerase eta in homologous DNA recombination and translesion DNA synthesis.

Takuo Kawamoto1, Kasumi Araki, Eiichiro Sonoda, Yukiko M Yamashita, Kouji Harada, Koji Kikuchi, Chikahide Masutani, Fumio Hanaoka, Kazuhiko Nozaki, Nobuo Hashimoto, Shunichi Takeda.   

Abstract

Chicken B lymphocyte precursors and DT40 cells diversify their immunoglobulin-variable (IgV) genes through homologous recombination (HR)-mediated Ig gene conversion. To identify DNA polymerases that are involved in Ig gene conversion, we created DT40 clones deficient in DNA polymerase eta (poleta), which, in humans, is defective in the variant form of xeroderma pigmentosum (XP-V). Poleta is an error-prone translesion DNA synthesis polymerase that can bypass UV damage-induced lesions and is involved in IgV hypermutation. Like XP-V cells, poleta-disrupted (poleta) clones exhibited hypersensitivity to UV. Remarkably, poleta cells showed a significant decrease in the frequency of both Ig gene conversion and double-strand break-induced HR when compared to wild-type cells, and these defects were reversed by complementation with human poleta. Our findings identify a DNA polymerase that carries out DNA synthesis for physiological HR and provides evidence that a single DNA polymerase can play multiple cellular roles.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16337602     DOI: 10.1016/j.molcel.2005.10.016

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  110 in total

1.  Targeting the FANCJ-BRCA1 interaction promotes a switch from recombination to poleta-dependent bypass.

Authors:  J Xie; R Litman; S Wang; M Peng; S Guillemette; T Rooney; S B Cantor
Journal:  Oncogene       Date:  2010-02-22       Impact factor: 9.867

2.  Participation of mouse DNA polymerase iota in strand-biased mutagenic bypass of UV photoproducts and suppression of skin cancer.

Authors:  Chad A Dumstorf; Alan B Clark; Qingcong Lin; Grace E Kissling; Tao Yuan; Raju Kucherlapati; W Glenn McGregor; Thomas A Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-17       Impact factor: 11.205

3.  Involvement of Rad18 in somatic hypermutation.

Authors:  Jürgen Bachl; Isin Ertongur; Berit Jungnickel
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-27       Impact factor: 11.205

4.  Induction and repair of zinc-finger nuclease-targeted double-strand breaks in Caenorhabditis elegans somatic cells.

Authors:  Jason Morton; M Wayne Davis; Erik M Jorgensen; Dana Carroll
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-23       Impact factor: 11.205

5.  DNA polymerase delta is preferentially recruited during homologous recombination to promote heteroduplex DNA extension.

Authors:  Laurent Maloisel; Francis Fabre; Serge Gangloff
Journal:  Mol Cell Biol       Date:  2007-12-17       Impact factor: 4.272

6.  What a difference a decade makes: insights into translesion DNA synthesis.

Authors:  Wei Yang; Roger Woodgate
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-26       Impact factor: 11.205

7.  Roles of exonucleases and translesion synthesis DNA polymerases during mitotic gap repair in yeast.

Authors:  Xiaoge Guo; Sue Jinks-Robertson
Journal:  DNA Repair (Amst)       Date:  2013-11-05

8.  Pirh2 E3 ubiquitin ligase targets DNA polymerase eta for 20S proteasomal degradation.

Authors:  Yong-Sam Jung; Gang Liu; Xinbin Chen
Journal:  Mol Cell Biol       Date:  2009-12-14       Impact factor: 4.272

9.  Biochemical analysis of active site mutations of human polymerase η.

Authors:  Samuel C Suarez; Renee A Beardslee; Shannon M Toffton; Scott D McCulloch
Journal:  Mutat Res       Date:  2013-03-13       Impact factor: 2.433

10.  The 9-1-1 DNA clamp is required for immunoglobulin gene conversion.

Authors:  Alihossein Saberi; Makoto Nakahara; Julian E Sale; Koji Kikuchi; Hiroshi Arakawa; Jean-Marie Buerstedde; Kenichi Yamamoto; Shunichi Takeda; Eiichiro Sonoda
Journal:  Mol Cell Biol       Date:  2008-07-28       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.